Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Leica TCS SP8 STED 3X - Fast and Direct 3D Super-resolution

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
See the full spectrum of life - with the smallest confocal volume ever.

Leica Microsystems continues to extend the capabilities of confocal super-resolution with its new STED platform Leica TCS SP8 STED 3X.

The first presentation to the public will be at the annual meetings of the Society for Neuroscience in San Diego, USA, and of the American Society for Cell Biology in New Orleans, USA, during November and December 2013 respectively.

The 3D STED system Leica TCS SP8 STED 3X achieves resolutions below the diffraction limit in lateral as well as axial directions. It offers the freedom to optimize resolution in all dimensions and to choose the setting that optimally fits the scientific question.

The system is freely adjustable for the best lateral resolution, best vertical resolution and smallest confocal volume.

Additionally, Leica TCS SP8 STED 3X offers multiple depletion laser choices that open up the spectrum of visible light for confocal super-resolution and give improved capabilities for research imaging.

The investigation of subcellular architecture and cell dynamics in living cells is an exciting challenge in life science research.

STED (STimulated Emission Depletion) is the only purely optical microscopy technology that yields resolution of structures below 50 nm without data processing.

The extension of STED technology to the third dimension and the freedom to use even more fluorophores raises super-resolution to a new level.

Leica Microsystems’ new STED super-resolution system is based on the Leica TCS SP8 confocal platform.

Due to its modular concept, upgrading a Leica TCS SP8 to Leica TCS SP8 STED 3X is possible at any time.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Markus Lusser is New President of Leica Microsystems
Appointment became effective July 1, 2015.
Wednesday, August 12, 2015
Yale University and Leica Microsystems Partner
Yale welcomes scientists to participate in core facility opening and super-resolution workshops October 20 through 31, 2014.
Tuesday, September 30, 2014
Leica Microsystems and Leica Biosystems Strengthen Market Position in Brazil
Long-standing Leica distributors Aotec have been acquired.
Tuesday, April 23, 2013
Leica Microsystems and Bausch + Lomb Sign Global Agreement
Bausch + Lomb to distribute Leica Microsystems’ medical products to ophthalmic customers in select global markets.
Friday, April 19, 2013
R&D 100 Award for Super-Resolution Microscope from Leica Microsystems
Leica SR GSD convinces jury with unprecedented performance in fluorescence microscopy.
Monday, August 06, 2012
Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions
High-tech market leader is set to boost growth with a local presence in India.
Thursday, November 17, 2011
License Agreement Between Leica Microsystems, the Max Planck Society and DKFZ
Developing the next Stimulated Emission Depletion microscopy generation.
Monday, November 14, 2011
Leica Announces new Chief Financial Officer
Martin Geisel has been announced as new CFO.
Monday, October 02, 2006
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos